Connect with us
Prague Gaming & TECH Summit 2024

Fintech PR

Cristóbal Conde Appointed Chairman of FinTech and GovTech Leader Fimatix

Published

on

 

Fimatix has announced the appointment of Cristóbal Conde as Non-Executive Chairman effective from 23 March 2021. Formerly Chairman of Calastone, the major global funds network recently sold to The Carlyle Group (NASDAQ: CG), Conde brings a wealth of business, fintech and investment experience. He will work closely with the senior management team as Fimatix continues its growth and M&A drive, identifying opportunities to acquire other fintech and govtech firms.

Conde has a strong track record of accelerating the growth of fintech companies. In 1983 Conde co-founded a financial technology software business, Devon Systems, serving the derivatives markets globally. After SunGard acquired Devon Systems in 1987, Conde ran his business as a division of the parent company, growing it into one of the largest businesses at SunGard. Conde was subsequently promoted to run the entire SunGard business, which he took private in 2005 in a record-breaking $11.3bn LBO transaction. Conde stepped down from SunGard in May 2011, by which time the technology giant had revenues of $5.6bn, employed over 25,000 globally, was ranked 380th on the Fortune 500 list and was the largest privately held business software and IT services company in the world.

Conde’s appointment follows the recent appointment of Tim Howarth as Chief Executive of Fimatix. Together they will work closely with senior colleagues including Stephen O’Sullivan, with a focus on strategy and M&A; Paul James, COO; Jeremy Renwick, – Innovation; and Hugh Ivory, Business Operations and Corporate Governance who is driving the growth of the business in Ireland.

Cris Conde said, on his appointment: “I am delighted to take on the role of Chairman. Fimatix has such strong expertise in delivering innovative products and services, digital transformation, agile coaching and solving problems with innovative tech. This is an exciting time for the business and I am proud to be working with the management team as they execute the roadmap to further growth, through building strong solutions and targeted acquisitions.”

Tim Howarth, CEO of Fimatix, said: “We are honoured that Cris will be taking the role of Chairman. His insight and experience of building successful businesses will be a great asset to Fimatix as we continue to target organic growth and acquisitions. As a company we want to provide technological innovation, and solutions that are relevant to client demands, for the good of society, the economy and people around the world. Chris shares our values and ambition for Fimatix and we are pleased to welcome him to the board.”

Conde joins the company a year since the merger of Fimatix and Agilesphere. With a team of over 150 staff, partners and associates, and offices in London and Newcastle, the combined company has a good foundation from which it offers services at scale. Since the merger, Fimatix has launched ‘Shield’, an independent COVID-19 track and trace system used in schools and workplaces, ‘Talent as a Service’, supporting HR teams and specialist advice services on IR35 and recruitment, Privacy4cars in the UK and continues to provide long term transformation support to the UK Government as a top 20 Digital Outcomes and Specialist supplier.

Fimatix’s purpose is to enhance the productivity of business and governments to the benefit of economies, communities and people around the world. The business has a track record of supporting major banks and e-money fintech challengers within the financial services sector and businesses in the leisure industry. The team enables digital transformation in UK Government including the Department of Health and Social Care, the Ministry of Justice, the Department for Work and Pensions and the Ministry of Housing, Communities and Local Government.

Fintech PR

Sygnum tokenises Matter Labs’ treasury reserves in USD 6.9bn Fidelity MMF

Published

on

sygnum-tokenises-matter-labs’-treasury-reserves-in-usd-6.9bn-fidelity-mmf
  • On behalf of its client Matter Labs, Sygnum is investing USD 50m into Fidelity’s Institutional Liquidity Fund (ILF)
  • Sygnum generates on-chain representation by issuing security tokens that act
    as secure and transparent “Proof-of-Reserves” for Matter Labs’ treasury reserves
  • Represents first step in Matter Labs’ long-term strategy to move its treasury
    reserves on-chain with trusted institutional custodians
  • By tokenising traditional securities, Sygnum is strengthening the Crypto-TradFi bridge and laying the foundations for a fully-tokenised ecosystem

ZURICH, March 19, 2024 /PRNewswire/ — Sygnum, a global digital asset banking group, is tokenising USD 50m of Matter Labs’ treasury reserves onto the zkSync blockchain. The Sygnum-issued security tokens act as on-chain representations of units from Fidelity International’s (“Fidelity”) USD 6.9bn[i] Institutional Liquidity Fund (ILF) to generate a secure and transparent “Proof-of-Reserves.”

Matter Labs is a software development, engineering, and cryptography company focused on creating scaling solutions for Ethereum and contributing to the improvement of zk-rollup technology, such as zkSync. zkSync is a layer 2 blockchain protocol designed to scale the performance of Ethereum, the second largest cryptocurrency. The investment marks the first step of Matter Labs’ long-term strategy to move its treasury reserves on-chain with institutional custodians like Sygnum.

This is the first project to leverage the capabilities of Sygnum’s multi-chain tokenisation solution with traditional securities. With the tokenisation of the investment in Fidelity’s money market fund, Sygnum further strengthens Crypto-TradFi connections and lays the foundations for a fully-tokenised ecosystem.

Jürg Rimle, Country Head Switzerland at Fidelity International, says “We welcome the partnership with Sygnum Bank that expands access for professional and institutional investors – and strengthens the trusted bridge between the emerging digital asset economy and traditional finance.”

Fatmire Bekiri, Sygnum Head of Tokenisation, says “Working with Fidelity and utilising zkSync, Sygnum leverages both the power of the blockchain and the experience of a global Tier 1 investment manager. It’s a prime illustration of our mission to connect Crypto and Trad-Fi and build Future Finance on-chain.”

Marco Cora, Matter Labs SVP of Business and Operations, says “Moving USD 50m of our treasury reserves onto the zkSync blockchain showcases its institutional-grade security as well as our commitment to transparency. We’re eager to collaborate with Sygnum to bring part of the Fidelity money market fund on the zkSync blockchain for investors.”

Matter Labs’ strategic move bringing its treasury reserves on-chain is part of the growing Real World Assets (RWA) tokenisation trend which in 2023 increased 74% to USD 2.5bn[ii]. Their enhanced liquidity and accessibility – as well as the increased attractiveness of traditional yield-bearing instruments – is driving new levels of transparency, efficiency and new product creation in financial markets.

About Sygnum

Sygnum is a global digital asset banking group, founded on Swiss and Singapore heritage. We empower professional and institutional investors, banks, corporates and DLT foundations to invest in digital assets with complete trust. Our team enables this through our institutional-grade security, expert personal service and portfolio of regulated digital asset banking, asset management, tokenisation and B2B services. In Switzerland, Sygnum holds a banking licence and has CMS and Major Payment Institution Licences in Singapore. The group is also regulated in the established global financial hubs of Abu Dhabi and Luxembourg. We believe that the future has heritage. Our crypto-native team of banking, investment and digital asset technology professionals are building a trusted gateway between the traditional and digital asset economies that we call Future Finance. To learn more about how Sygnum’s mission and values are shaping this digital asset ecosystem, please visit sygnum.com

Media contact:

Dominic Castley, Chief Marketing Officer
[email protected]
+41 58 508 21 01

Sygnum Bank AG
Uetlibergstrasse 134a 8045
Zurich, Switzerland

Disclaimer: The information in this publication pertaining to Sygnum Bank AG (“Sygnum”) is for general information purposes only, as per date of publication and should not be considered exhaustive. This publication does not consider the financial situation of any natural or legal person, nor does it provide any tax, legal or investment advice. This publication does not constitute any advice or recommendation, an offer or invitation by or on behalf of Sygnum to purchase or sell any assets. When making an investment decision, you should either conduct your own research and analysis or seek advice from an expert. No elements of precontractual or contractual relationship are intended. While the information is believed to be from accurate and reliable sources, Sygnum makes no representation or warranties, expressed or implied, as to the accuracy of the information and Sygnum expressly disclaims any and all liability that may be based on such information, omissions, or errors thereof. If nothing is indicated to the contrary, all figures are unaudited. Any statements contained in this publication attributed to a third party represent Sygnum’s interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. Sygnum reserves the right to amend or replace the information, in part or entirely, at any time, and without any obligation to notify the recipient of such amendment / replacement or to provide the recipient with access to the information. Simultaneously, there is no obligation of Sygnum to inform recipients of information, if before provided information later becomes outdated, inaccurate or obsolete, unless otherwise provided by applicable law. The information provided is not intended for use by or distributed to any individual or legal entity in any jurisdiction or country where such distribution, publication or use would be contrary to the law or regulatory provisions or in which Sygnum does not hold the necessary registration, approval authorization or license. Except as otherwise provided by Sygnum, it is not allowed to modify, copy, distribute or reproduce, display, license, or otherwise use any content for commercial purposes. The information herein refers to products and services of Sygnum and therefore constitutes advertising according to Art. 68 of the Swiss Financial Services Act (“FinSA”). Nonetheless, this document contains only general material and does not consider the financial situation of any natural or legal person, nor does it provide any tax, legal or investment advice. In particular, this publication does not constitute (i) any advice or recommendation, an offer or invitation by or on behalf of Sygnum to purchase or sell any assets; (ii) an inducement or incitement to participate in any product, offering or investment; (iii) a prospectus or key information document according to Swiss laws and regulations; nor shall it be construed as such. Where applicable, the full offering documentation of the products mentioned in this publication (such as for example the prospectus, offering memorandum, key information document (Basisinformationsblatt) may be obtained free of charge at Sygnum Bank AG, Uetlibergstrasse 134a, 8045 Zurich, Switzerland and/or by contacting us at https://www.sygnum.com/contact/. Some of the products mentioned in this publication might not qualify as units of a collective investment scheme according to the relevant provisions of the Swiss Federal Act on Collective Investment Schemes (“CISA”), as amended, and are not licensed thereunder. Therefore, neither such products nor the issuer is governed by the CISA nor approved by the Swiss Financial Market Supervisory Authority FINMA (“FINMA”). Accordingly, for such products investors do not have the benefit of the specific investor protection provided under the CISA. These materials and this publication are for distribution only under such circumstances as may be permitted by applicable laws. They are not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or would subject Sygnum or its partners to any registration, licensing or other legal requirement within such jurisdiction. Unless explicitly stated otherwise, no action has been or will be taken by Sygnum or its partners that would permit a public offering or a distribution of the products or possession or distribution of any offering material in relation to the products in any jurisdiction where action for that purpose is required. No offers, sales, resales or deliveries of any products or distribution of any offering material relating to any products may be made in or from any jurisdiction except in circumstances which will result in compliance with any applicable laws and regulations, and which will not impose any obligation on Sygnum. Where applicable, if and to the extent Sygnum has registered its prospectus with a prospectus evaluation body or a regulatory authority, further reference regarding the applicable selling and transfer restrictions is made to such prospectus. These materials may include statements that are, or may be deemed to be, “forward-looking statements”. These forward-looking statements include, for example, the terms “believes”, “estimates”, “plans”, “projects”, “anticipates”, “expects”, “intends”, “may”, “will” or “should” or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Forward-looking statements speak only as of the date they are made. Without prejudice to any requirements under applicable laws and regulations, Sygnum and each of the participating authorized participants expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in these materials to reflect any change in expectations thereof or any change in events, conditions or circumstances on which any such forward-looking statement is based, whether as a result of new information, future developments or otherwise. These materials are not a complete statement of the markets and developments referred to herein. Where applicable, some figures may refer to past performances or simulated past performances and past performance is not a reliable indicator of future results. Some figures may be forecasts only and forecasts are not a reliable indicator of future performance. Investment decisions should always be taken in a portfolio context and make allowance for your personal situation and consequent risk appetite and risk tolerance. No reliance may be placed for any purpose on the information contained in these materials or its accuracy or completeness. None of the participating authorized offerors, authorized participants, or distributors or any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in these materials (or whether any information has been omitted from them) or any other information relating to Sygnum or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of these materials or its contents or otherwise arising in connection therewith. 

About Matter Labs

Matter Labs is a leading research and development company focused on the creation of scaling solutions for Ethereum and other blockchains. The company is a pioneer in zero-knowledge proof technology, which it leverages to build blockchain infrastructure that enables fast, secure, and scalable transactions. With a commitment to privacy and decentralization, Matter Labs is driving the next wave of innovation in blockchain technology.    

About zkSync

zkSync uses cutting-edge zero-knowledge (ZK) technology to scale Ethereum and bring crypto to the mainstream — reaching millions of developers and billions of people in need of a technological solution for achieving progress and prosperity.  zkSync makes it possible for enterprises and financial institutions to easily deploy their app-chain, setting their custom privacy requirements, all while remaining interoperable with other chains and without compromising on security and performance.

Deeply rooted in its mission to advance personal freedom for all, the zkSync blockchain network makes digital self-ownership universally available. It is trustless, secure, reliable, censorship-resistant, privacy-preserving, hyper-scalable, accessible, and sovereign. To learn more about zkSync, visit zksync.io.         

About Fidelity International

Fidelity International offers investment solutions and services and retirement expertise to more than 2.9 million customers globally. As a privately held, purpose-driven company with a 50-year heritage, we think generationally and invest for the long term. Operating in more than 25 locations and with $776.2 billion in total assets, our clients range from central banks, sovereign wealth funds, large corporates, financial institutions, insurers, and wealth managers, to private individuals.

Our Workplace & Personal Financial Health business provides individuals, advisers and employers with access to world-class investment choices, third-party solutions, administration services and pension guidance. Together with our Investment Solutions & Services business, we invest $560.4 billion on behalf of our clients. By combining our asset management expertise with our solutions for workplace and personal investing, we work together to build better financial futures. Data as at 31 December 2023. Read more at fidelityinternational.com.

[i] As at end of February 2024

[ii] Galaxy Digital: Overview of On-Chain RWAs and the Forces Propelling their Growth

 

Logo – https://mma.prnewswire.com/media/2365944/Sygnum_Logo.jpg
Logo – https://mma.prnewswire.com/media/2365943/Matter_Labs_Logo.jpg

 

 

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sygnum-tokenises-matter-labs-treasury-reserves-in-usd-6-9bn-fidelity-mmf-302092659.html

Continue Reading

Fintech PR

PharmaVentures acts as the exclusive M&A advisor on the successful sale of Phasefocus to Bruker

Published

on

pharmaventures-acts-as-the-exclusive-m&a-advisor-on-the-successful-sale-of-phasefocus-to-bruker

LONDON, March 19, 2024 /PRNewswire/ — PharmaVentures is pleased to announce that it acted as the exclusive advisor to Phasefocus Holdings Limited on its sale to Bruker (NASDAQGS:BRKR).

Phasefocus is a privately held company that has leading expertise in imaging, image processing algorithms and imaging platform. Phasefocus has deployed their expertise to develop a novel optical microscope, called Livecyte, for label-free cell imaging. Phasefocus’ microscopy capabilities will enhance Bruker’s existing portfolio, enabling new research advances.

Adrian Dawkes, Managing Director at PharmaVentures, said: “We are delighted to have leveraged our network and capabilities in M&A to deliver this successful outcome for Phasefocus shareholders. It is particularly pleasing to help this innovative UK technology company gain commercial validation from Bruker, a global player in the imaging, material and life science research sector.” Fintan Walton, Chairman and Chief Executive at PharmaVentures added: “This transaction endorses our firm as a leading player in cross border life sciences M&A.”

Financial details of the transaction were not disclosed.

For further information, please contact:
Adrian Dawkes
Managing Director
[email protected]
+44 (0)7931 428487

About PharmaVentures

PharmaVentures Ltd is a premier life science transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For over 30 years, PharmaVentures has acted as advisor on over 1000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide.

PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts from innovators to large pharma makes us uniquely placed to support business in all aspects of deal making and strategic planning.

PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.

PharmaVentures’ services include:

  • M&A (divestments, mergers, acquisitions, and strategic transactions)
  • Licensing (in and out licensing)
  • Fundraising Support
  • Strategy (commercialisation, deal strategy, due diligence, market entry)
  • Valuations (licensing, M&A, and fundraising)
  • Pricing and Market Access

PharmaVentures is based in London, UK, and employs over 30 professionals and has associates in Europe and Asia-Pacific.

NOTE: This Press release is issued by PharmaVentures Limited, whose wholly owned subsidiary PharmaVentures Capital Limited is authorised and regulated by the Financial Conduct Authority (741356). This communication is for information purposes only and does not constitute an offer or solicitation to purchase or engage in any investment products, securities or services and should not be deemed as such.

For more details, visit https://www.pharmaventures.com
Follow us on LinkedIn: https://www.linkedin.com/company/pharmaventures/

About Phasefocus

Based in Sheffield, UK, Phasefocus is a private company founded in 2006 from University of Sheffield research. Phasefocus is changing what is possible in live cell assays, helping scientists uncover subtle differences in cell behaviour across whole cell populations. Livecyte, Phasefocus’s flagship product, delivers an unprecedented level of single cell data from live cells. High-contrast label-free imaging, correlative fluorescence and powerful automated image analysis algorithms result in high-content time-lapse outputs from standard 96-well plate assays.

View original content:https://www.prnewswire.co.uk/news-releases/pharmaventures-acts-as-the-exclusive-ma-advisor-on-the-successful-sale-of-phasefocus-to-bruker-302092131.html

Continue Reading

Fintech PR

Norque to Launch First Blazing Fast, Secure AI and ML-Enabled Blockchain, DEX, CEX, Instant Payment via Cryptocurrency Application and Real Usability Coin/Token with Insurance Integration for Users and Stakeholders

Published

on

norque-to-launch-first-blazing-fast,-secure-ai-and-ml-enabled-blockchain,-dex,-cex,-instant-payment-via-cryptocurrency-application-and-real-usability-coin/token-with-insurance-integration-for-users-and-stakeholders

Norque for Security, Usability, Accessibility and Sustainability for Blockchain, Web3, Cryptocurrency, Metaverse and Physical world by integrating Artificial Intelligence, Machine Learning technology and Risks Mitigation offerings.

SAN FRANCISCO, March 19, 2024 /PRNewswire/ — Norque is coming with its ICO around April/May 2024 introducing a pioneering ecosystem that merges blockchain, AI, ML, cryptocurrency, and insurance, marking a first in the sector. Norque aims to bring security, usability, accessibility, and sustainability to the blockchain, Web3, cryptocurrency, and the metaverse.

In response to the cryptocurrency market’s volatility and high-profile failures, Norque presents a novel approach by offering a digital currency with real-world value. Unlike previous projects that pursued fleeting fame LUNA, Doge and FTX, Norque focuses on providing actual utility backed by tangible assets, such as real estate and consumer goods.

Norque’s foundation is built on expertise from blockchain professionals, financial market experts, AI specialists, and global influencers. It introduces the first AI and ML-driven blockchain tailored for insurance claim settlements, enhancing efficiency and accessibility. Additionally, the project launches NOQ, a token underpinned by real-world assets, enabling purchases across blockchain, crypto, metaverse, and insurance services.

https://youtu.be/GtXLgA7IxK0 

A standout feature is the introduction of the first Decentralized Exchange (DEX) and a unique Centralized Exchange (CEX) with integrated insurance capabilities and AI and ML functionalities. These platforms are designed to redefine reliability and functionality in decentralized and centralized finance.

Norque’s comprehensive insurance solutions cater to crypto investors, institutions, exchanges, and metaverse participants, addressing the critical need for risk mitigation in the crypto space. This initiative aims to boost confidence and stability, setting a new benchmark in the industry.

The project also unveils an application facilitating seamless crypto payments and currency conversions, empowering users to make purchases ranging from daily necessities to significant assets with cryptocurrency. Certik certification is in process.

P. Nakamoto himself, in a guest show, highlights the project’s ambition to exceed the practical applications of predecessors by leveraging real-world asset backing and addressing market volatility through innovative risk mitigation strategies. Norque’s introduction is timely, aiming to foster stability and promote wider adoption amid the challenges faced by the crypto and metaverse sectors.

To know more: www.norque.io.

https://youtu.be/pNWnr8UM0xc 

Join the Norque Universe:

twitter.com/NorqueNoq
https://norque.medium.com/
https://discord.gg/NdHtsKa4va
https://t.me/NORQUE_NOQ
https://t.me/ConvalexaNOQ
https://www.reddit.com/r/NOQ/

Contact:  Mr. Jes Jim, [email protected], +44-7361627958

Infographic – https://mma.prnewswire.com/media/2364200/Norque_Infographic.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/norque-to-launch-first-blazing-fast-secure-ai-and-ml-enabled-blockchain-dex-cex-instant-payment-via-cryptocurrency-application-and-real-usability-cointoken-with-insurance-integration-for-users-and-stakeholders-302091306.html

Continue Reading

Trending